Explanatory variables | Sub-categories | Mean (SD) | Median [Q1–Q3] | [Min–max] |
---|---|---|---|---|
Study design | SR/MA | 14.9 (37.0) | 3.5 [1.0–10.0] | [0.0–268.0] |
RCT | 20.7 (50.5) | 3.0 [0.0–16.0] | [0.0–428.0] | |
Phase I/II, non-RCT | 6.5 (17.2) | 2.0 [0.0–4.0] | [0.0–139.0] | |
Observational study | 13.4 (39.7) | 2.0 [0.0–7.0] | [0.0–319.0] | |
Abstract conclusion | In favour of study treatment | 16.6 (44.8) | 2.0 [0.0–9.0] | [0.0–428.0] |
Not in favour of study treatment | 11.5 (32.5) | 2.0 [0.0–7.0] | [0.0–319.0] | |
Funding source | Profit | 13.9 (41.1) | 2.0 [0.0–9.0] | [0.0–370.0] |
Non-profit | 15.4 (41.1) | 2.0 [0.0–8.0] | [0.0–428.0] | |
Open access | Yes | 17.9 (49.3) | 3.0 [1.0–8.0] | [0.0–428.0] |
No | 10.6 (24.8) | 1.5 [0.0–8.0] | [0.0–258.0] | |
Press release | Yes | 118.6 (87.5) | 84.5 [58.0–144.5] | [29.0–428.0] |
No | 7.0 (19.0) | 2.0 [0.0–5.0] | [0.0–268.0] |